Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Suppr

超能文献

作者信息

Greco A V, Crucitti F, Ghirlanda G, Manna R, Altomonte L, Rebuzzi A G, Bertoli A

出版信息

Diabetologia. 1979 Jul;17(1):23-8. doi: 10.1007/BF01222973.

DOI:10.1007/BF01222973

PMID:467851

Abstract

摘要

相似文献

Insulin and glucagon concentrations in portal and peripheral veins in patients with hepatic cirrhosis.

Diabetologia. 1979 Jul;17(1):23-8. doi: 10.1007/BF01222973.

Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.

Diabete Metab. 1980 Jun;6(2):117-27.

Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.

Acta Endocrinol (Copenh). 1981 Aug;97(4):496-502. doi: 10.1530/acta.0.0970496.

Portal blood flow and glucose tolerance or peripheral insulin and glucagon concentrations in patients with liver cirrhosis.

Pancreas. 2002 Jan;24(1):109-10. doi: 10.1097/00006676-200201000-00016.

Elevated plasma glucagon levels in cirrhosis of the liver.

N Engl J Med. 1973 Nov 22;289(21):1107-11. doi: 10.1056/NEJM197311222892103.

[Pulsatile insulin secretion into the portal vein in liver cirrhosis].

Dtsch Med Wochenschr. 1993 Feb 5;118(5):134-8. doi: 10.1055/s-2008-1059310.

Glucagon and glucose tolerance in liver cirrhosis.

Acta Endocrinol (Copenh). 1988 Jul;118(3):337-45. doi: 10.1530/acta.0.1180337.

Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.

Acta Diabetol Lat. 1974 Jul-Aug;11(4):330-9. doi: 10.1007/BF02581236.

Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.

J Endocrinol Invest. 1981 Jan-Mar;4(1):1-5. doi: 10.1007/BF03349405.

Portal and peripheral vein concentrations of insulin and glucagon after arginine infusion in morbidly obese subjects.

Metabolism. 1980 Oct;29(11):1037-40. doi: 10.1016/0026-0495(80)90213-9.

引用本文的文献

High Doses of Exogenous Glucagon Stimulate Insulin Secretion and Reduce Insulin Clearance in Healthy Humans.

Diabetes. 2024 Mar 1;73(3):412-425. doi: 10.2337/db23-0201.

Physiological significance of bistable circuit design in metabolic homeostasis: role of integrated insulin-glucagon signalling network.

Mol Biol Rep. 2022 Jun;49(6):5017-5028. doi: 10.1007/s11033-022-07175-w. Epub 2022 Jan 25.

Physiological effects of intraperitoneal versus subcutaneous insulin infusion in patients with diabetes mellitus type 1: A systematic review and meta-analysis.

PLoS One. 2021 Apr 13;16(4):e0249611. doi: 10.1371/journal.pone.0249611. eCollection 2021.

Morphological and biochemical changes in the pancreas associated with acute systemic hypoxia.

Hum Cell. 2021 Mar;34(2):400-418. doi: 10.1007/s13577-020-00481-0. Epub 2021 Feb 2.

Frequency and Causes of False-Positive Elevated Plasma Concentrations of Fasting Gut Hormones in a Specialist Neuroendocrine Tumor Center.

Front Endocrinol (Lausanne). 2020 Dec 16;11:606264. doi: 10.3389/fendo.2020.606264. eCollection 2020.

Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion.

JCI Insight. 2017 Mar 23;2(6):e91863. doi: 10.1172/jci.insight.91863.

Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog.

Diabetes. 2014 Nov;63(11):3946-54. doi: 10.2337/db14-0266. Epub 2014 Jun 19.

Effects of transmitters and interleukin-10 on rat hepatic fibrosis induced by CCl4.

World J Gastroenterol. 2003 Mar;9(3):539-43. doi: 10.3748/wjg.v9.i3.539.

Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Gut. 2002 Dec;51(6):870-5. doi: 10.1136/gut.51.6.870.

The effects of intraoperative glucose infusion on portal blood insulin concentration and hepatic mitochondrial redox state during surgery: comparison of short-term and continuous infusions.

Surg Today. 2000;30(3):228-34. doi: 10.1007/s005950050050.

本文引用的文献

Studies on tissue uptake of insulin in man using a differential immunoassay for endogenous and exogenous insulin.

J Clin Invest. 1961 Nov;40(11):2092-102. doi: 10.1172/JCI104435.

PROPERTIES OF A GLUCAGON-DEGRADING ENZYME OF BEEF LIVER.

J Biol Chem. 1964 Jul;239:2160-4.

Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion.

J Clin Invest. 1962 Apr;41(4):682-9. doi: 10.1172/JCI104525.

Metabolism of insulin-I 131; studies in isolated, perfused rat liver and hindlimb preparations.

Diabetes. 1959 Jul-Aug;8(4):307-14. doi: 10.2337/diab.8.4.307.

The relationship between the mechanism of action of the sulfonylureas and the secretion of insulin into the portal circulation.

Ann N Y Acad Sci. 1959 Mar 30;74(3):548-56. doi: 10.1111/j.1749-6632.1959.tb39579.x.

[Measurement of glucose assimilation; theoretical bases and clinical applications].

Acta Gastroenterol Belg. 1955 Jul-Aug;18(7-8):655-705; contd.

Plasma insulin responses to glucose in femoral, hepatic, and pancreatic veins in dogs.

Am J Physiol. 1966 Aug;211(2):442-8. doi: 10.1152/ajplegacy.1966.211.2.442.

Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.

Arch Intern Med. 1969 Aug;124(2):149-52.

Glucose intolerance and insulin resistance in patients with liver disease.

Arch Intern Med. 1969 Aug;124(2):142-8.

Decreased insulin production, elevated growth hormone levels, and glucose intolerance in liver disease.

J Lab Clin Med. 1969 Jan;73(1):25-33.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验